Filing Details
- Accession Number:
- 0001181431-13-048713
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-09-12 09:23:59
- Reporting Period:
- 2013-09-10
- Filing Date:
- 2013-09-12
- Accepted Time:
- 2013-09-12 09:23:59
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1533040 | Rxi Pharmaceuticals Corp | RXII | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1285648 | Geert Cauwenbergh | C/O Rxi Pharmaceuticals Corporation 1500 West Park Drive, Suite 210 Westborough MA 01581 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.0001 Par Value | Acquisiton | 2013-09-10 | 200 | $3.65 | 14,700 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2013-09-10 | 150 | $3.58 | 14,850 | No | 4 | P | Direct | |
Common Stock, $0.0001 Par Value | Acquisiton | 2013-09-11 | 150 | $3.55 | 15,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Direct |